Delta Asset Management LLC Bio Techne Corp Transaction History

Delta Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $8,873 - $38,751	110 New	110 $9,000
Q1 2022 May 12, 2022	SELL	$353.85 - $487.79 $17,692 - $24,389	-50 Closed	0 $0
Q2 2020 Jul 23, 2020	SELL	$185.43 - $279.56 $2,781 - $4,193	-15 Reduced 23.08%	50 $13,000
Q3 2019 Oct 31, 2019	BUY	$183.56 - $216.72 $11,931 - $14,086	65 New	65 $13,000
Q1 2018 Apr 26, 2018	SELL	$131.46 - $151.04 $1,051 - $1,208	-8 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$113.59 - $123.78 $908 - $990	8	8 $1,000

616

155M

161K

12.7K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $1.95B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Delta Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Asset Management LLC with notifications on news.